Raleigh Capital Management’s Amgen AMGN Stock Holding History

Raleigh Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Buy	4,020 +9	+0.2%	+$3.08K	0.46%	66
2026 Q1	$1.41M	Sell	4,011 -2,316	-37%	-$826K	0.49%	60
2025 Q4	$2.07M	Sell	6,327 -520	-8%	-$165K	0.75%	40
2025 Q3	$1.93M	Buy	6,847 +363	+6%	+$105K	0.73%	45
2025 Q2	$1.81M	Buy	6,484 +883	+16%	+$250K	0.76%	39
2025 Q1	$1.74M	Buy	5,601 +822	+17%	+$243K	0.79%	36
2024 Q4	$1.25M	Buy	4,779 +1,077	+29%	+$320K	0.48%	64
2024 Q3	$1.19M	Sell	3,702 -2,165	-37%	-$708K	0.46%	68
2024 Q2	$1.83M	Buy	5,867 +1,013	+21%	+$298K	0.78%	29
2024 Q1	$1.38M	Sell	4,854 -1,284	-21%	-$376K	0.6%	54
2023 Q4	$1.77M	Sell	6,138 -3,186	-34%	-$868K	0.82%	32
2023 Q3	$2.51M	Buy	9,324 +516	+6%	+$129K	1.28%	12
2023 Q2	$1.96M	Buy	8,808 +2,995	+52%	+$695K	0.98%	26
2023 Q1	$1.41M	Buy	5,813 +2,051	+55%	+$503K	0.7%	46
2022 Q4	$988K	Sell	3,762 -3,785	-50%	-$1.01M	0.51%	62
2022 Q3	$1.7M	Buy	7,547 +3,006	+66%	+$729K	0.99%	32
2022 Q2	$1.1M	Buy	4,541 +1,286	+40%	+$315K	0.63%	48
2022 Q1	$787K	Buy	+3,255	New	+$748K	0.43%	70

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Raleigh Capital Management's AMGN Position: Q2 2026 in Review

Raleigh Capital Management increased its Amgen (AMGN) stake by 0.22% in Q2 2026, buying an estimated $3.08K and bringing the position to 4,020 shares worth $1.46M. The position accounts for 0.46% of the portfolio, ranked #66.

Raleigh Capital Management first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.51M in Q3 2023. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Raleigh Capital Management held 4,020 shares of Amgen worth $1.46M as of Q2 2026.
Raleigh Capital Management bought 9 Amgen shares in Q2 2026, an estimated $3.08K.
Amgen made up 0.46% of Raleigh Capital Management's portfolio in Q2 2026, its #66 holding.
Raleigh Capital Management first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
Raleigh Capital Management's Amgen position peaked at $2.51M in Q3 2023.
836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.